Hales Donate $50 Million to Breast Cancer Research Foundation

By the Editorial Team · Saturday, October 17, 2026

Billionaires Rob and Karen Hale have donated $50 million to the Breast Cancer Research Foundation to create the Hale Family Collaborative and support innovative research and early-stage treatment companies. This unprecedented private gift aims to sustain critical breast cancer studies amid unstable federal funding and accelerate advances in key areas like metastatic disease and artificial intelligence.

Billionaire Boston philanthropists Rob and Karen Hale have pledged $50 million to the Breast Cancer Research Foundation (BCRF) to support scientific research amid a challenging federal funding environment, the organization announced Friday. The donation is being described as the largest private gift ever made to breast cancer research.

The funding will establish the Hale Family Collaborative of New England Investigators, a network intended to strengthen local research efforts at institutions receiving grants from BCRF. Additionally, $11 million from the gift will be directed to BCRF Ventures, an investment initiative aimed at advancing early-stage companies developing innovative breast cancer treatments.

Donna McKay, president and CEO of BCRF, emphasized the foundation’s flexibility in allocating the funds, highlighting five priority areas: breast cancer in younger women, metastatic disease, artificial intelligence, immunotherapy, and prevention. She noted that the donation will accelerate scientific progress at a time when federal support for research has become increasingly uncertain.

“The political landscape now is what it is. We all understand it, and it’s unfortunate,” said Karen Hale, who co-chairs the foundation’s board. She stressed the importance of consistent funding for long-term projects, many of which are nearing critical breakthroughs. “You can’t take a project that’s been going on for years and stop it. You lose all of that research,” she said.

Breast cancer remains the most common invasive cancer among women in Massachusetts, according to the state Department of Public Health data from 2017 to 2021.

The Hales have donated more than $500 million to various causes over their careers. Rob Hale is the CEO of Granite Telecommunications, a Quincy-based company, and has an estimated net worth of $6.5 billion, according to Forbes.

The donation holds personal significance for Karen Hale, whose mother was diagnosed with breast cancer nearly three decades ago. Her mother’s cancer later metastasized, and she currently receives regular infusions of Herceptin, a drug whose early development was funded in part by BCRF.

“She’s alive and she gets an infusion every three weeks, and she’s doing great,” Hale said.

While the foundation has not finalized the institutions that will participate in the Hale Family Collaborative, McKay said it is expected to include all leading New England research centers, from Dana-Farber Cancer Institute to Yale University. The initiative aims to foster collaboration akin to the foundation’s annual research retreat, where scientists exchange ideas and form new partnerships.

BCRF Ventures is focused on accelerating the translation of laboratory discoveries into patient treatments. McKay cited Boston-based Clarity Breast, an artificial intelligence tool that predicts breast cancer risk from mammograms, as an example of the type of innovation the fund supports.

For the 2026-27 cycle, the foundation has committed over $75 million to more than 280 researchers worldwide.

This article was reported by synthesizing coverage from multiple independent news outlets to present a balanced, unbiased account. Read about our editorial standards. Spotted an error? Let us know.